The worldwide explosion of obesity has resulted in an ever-increasing prevalence of type 2 diabetes. The importance of insulin resistance and β-cell dysfunction to the pathogenesis of type 2 diabetes was debated for a long time; many thought that insulin resistance was the main abnormality in type 2 diabetes, and that inability to secrete insulin was a late manifestation. This notion is now challenged. This presentation deals with the important contributing factors in the development of type 2 diabetes mellitus.
Shashikiran Umakanth made this presentation at the "First Endocrine Update Program” – ENDO EGYPT 2015, from 17-20 December 2015 in the Historic City of Luxor, Egypt. This endocrine update was organised by the Egyptian Association of Endocrinology , Diabetes and Atherosclerosis (EAEDA) in collaboration with the Endocrine Society, USA.
The worldwide explosion of obesity has resulted in an ever-increasing prevalence of type 2 diabetes. The importance of insulin resistance and β-cell dysfunction to the pathogenesis of type 2 diabetes was debated for a long time; many thought that insulin resistance was the main abnormality in type 2 diabetes, and that inability to secrete insulin was a late manifestation. This notion is now challenged. This presentation deals with the important contributing factors in the development of type 2 diabetes mellitus.
Shashikiran Umakanth made this presentation at the "First Endocrine Update Program” – ENDO EGYPT 2015, from 17-20 December 2015 in the Historic City of Luxor, Egypt. This endocrine update was organised by the Egyptian Association of Endocrinology , Diabetes and Atherosclerosis (EAEDA) in collaboration with the Endocrine Society, USA.
Type 2 diabetes - A 2016 update by Zeena NackerdienZeena Nackerdien
The International Diabetes Federation maintains that one in two adults are undiagnosed for diabetes and that estimates that one in eleven people had diabetes in 2015. If one takes into account that most of the cases involves the preventable condition of Type 2 diabetes, it comes as no surprise that many countries are being hit by staggering socioeconomic costs. Diabetes sites, chat rooms, aps, and ads for ever-evolving and increasingly complex disease management schemes are commonplace on Google. But what does all the information mean? The American Diabetes Association, American Association of Clinical Endocrinologists, The Canadian Diabetes Association, WebMD, and the International Diabetes Federation resources served as the major resources for this accompanying slide deck that tries to unpack some of the major subtopics related to prediabetes and Type 2 diabetes. The slide deck is organized according to disease definition, epidemiology, etiology/pathophysiology, diagnosis, treatment, and prevention. Particular topics such as the early use of insulin could be expanded into several separate slide decks narrating benefits and risks with supporting evidence. However, this deck is meant to provide interested readers with an overview of the Type 2 diabetes literature landscape, with the caveat that specific cases and Type 2 diabetes-related complications should always be discussed with a healthcare provider.
Image credits: slideteam.net; Wikimedia
Type 2 diabetes - A 2016 update by Zeena NackerdienZeena Nackerdien
The International Diabetes Federation maintains that one in two adults are undiagnosed for diabetes and that estimates that one in eleven people had diabetes in 2015. If one takes into account that most of the cases involves the preventable condition of Type 2 diabetes, it comes as no surprise that many countries are being hit by staggering socioeconomic costs. Diabetes sites, chat rooms, aps, and ads for ever-evolving and increasingly complex disease management schemes are commonplace on Google. But what does all the information mean? The American Diabetes Association, American Association of Clinical Endocrinologists, The Canadian Diabetes Association, WebMD, and the International Diabetes Federation resources served as the major resources for this accompanying slide deck that tries to unpack some of the major subtopics related to prediabetes and Type 2 diabetes. The slide deck is organized according to disease definition, epidemiology, etiology/pathophysiology, diagnosis, treatment, and prevention. Particular topics such as the early use of insulin could be expanded into several separate slide decks narrating benefits and risks with supporting evidence. However, this deck is meant to provide interested readers with an overview of the Type 2 diabetes literature landscape, with the caveat that specific cases and Type 2 diabetes-related complications should always be discussed with a healthcare provider.
Image credits: slideteam.net; Wikimedia
Infertility is defined as the inability of a couple to conceive after at least one year of regular unprotected intercourse.
Male infertility refers to a male's inability to cause pregnancy in a fertile female.
IDD situation in our country has improved
A good number of thyroid disorder patients are either undiagnosed and or untreated
Thyroid disorder in pregnancy- Rate high
As a sound thyroid functioning status is crucial for growth, development in children; reproduction, psychological and general wellbeing in adults, we must be proactive in screening, diagnosing and treating our patients.
Over the past several years it has been proved that maternal thyroid disorder influence the outcome of mother and fetus, during and also after pregnancy. The most frequent thyroid disorder in pregnancy is maternal hypothyroidism. It is associated with fetal loss, placental abruptions, pre-eclampsia, preterm delivery and reduced intellectual function in the offspring.1 In pregnancy, overt hypothyroidism is seen in 0.2% cases2 and sub clinical hypothyroidism in 2.3% cases3. Fetal loss, fetal growth restriction, pre-eclampsia and preterm delivery are the usual complications of overt hyperthyroidism (low TSH and high T3, T4) seen in 2 of 1000 pregnancies whereas mild or sub clinical hyperthyroidism (suppressed TSH alone) is seen in
1.7% of pregnancies and not associated with adverse outcomes4. Autoimmune positive euthyroid pregnancy shows doubling of incidence of miscarriage and preterm delivery. Worldwide more than 20 million people develop neurological sequel due to intra uterine, iodine deprivation5. Other problems of thyroid disorders in pregnancy are post partum thyroiditis, thyroid nodules and cancer, hyper emesis gravidarum etc. Debates and disputes persist regarding several protocol and management plan in this specific spectrum of diseases.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
1. Pathophysiology of
Type 2 Diabetes
Dr Shahjada Selim
Assistant Professor
Department of Endocrinology
Bangabandhu Sheikh Mujib Medical University, Dhaka
Email: selimshahjada@gmail.com
4. NORMAL FUEL METABOLISM
Fuel metabolism is regulated by complex system to:
• Distribute nutrients to organs and tissues for mechanical or
chemical work, growth or renewal
• Provide storage of excess nutrients: glycogen or fat
• Allow release of energy from storage depots as needed during
fasting or high energy use
5. Carbohydrate Metabolism
• Glucose is a major energy source for muscles
and the brain.
• The brain is nearly totally dependent on
glucose
• Muscles use Glucose And Fat for fuel.
• Main sources of circulating glucose are hepatic
glucose production, kidney and ingested
carbohydrate.
6. Basal Hepatic glucose production:
HGP
• After absorption of the last meal is
complete, liver produce glucose to supply
glucose needed for tissues that do not
store glucose as brain.
• ~2 mg/kg body wt/min in adults.
8. Mechanisms and sources of glucose
release in the post-absorptive state
Overall rate of glucose
release:
~10 μmol/(kg−min)
Renal contribution:
2.0–2.5
μmol/(kg−min)
(20–25%)
Hepatic contribution:
7.5–8.0
μmol/(kg−min)
(75–80%)
Renal
gluconeogenesis:
2.0–2.5
μmol/(kg−min)
(20–25%)
Hepatic
glycogenolysis:
4.5–5.5
μmol/(kg−min)
(45–50%)
Hepatic
gluconeogenesis:
2.5–3.0
μmol/(kg−min)
(25–30%)
9. High HGP In T2DM
• Insulin suppresses hepatic glucose production (HGP)
• In T2D: impaired hepatic insulin action (Liver
resistance): increase BGP: high FBG: diagnosis
• High HGP during fasting : hyperglycemia,
hyperlipidemia, and ketosis (RAMADAN
FASTING).
• Metformin: act on liver resistance. Taken at PM ,
lowers liver production of glucose at night, lowers
FBG .
10. Ingested carbohydrate
• 60–70% is stored (glycogen)
• 30-40% oxidized for immediate energy needs.
• Produce postprandial blood glucose 90–120 min after meal.
• The magnitude and rate of rise in BG:
– size of the meal
– physical state (solid, liquid, cooked, raw)
– other nutrients: fat and fiber: slow digestion
– amount and effect of insulin.
– Type simple or complex: least effect
– The rate of gastric emptying: delays PP surge with
hypoglycemia and rebound hyperglycemia
11. Protein Metabolism
Ingested protein is absorbed as amino
acids:
• synthesis of new protein
• oxidation to provide energy
• conversion to glucose (gluconeogenesis)
during fasting: Alanine
• In DM: gluconeogenesis: loss of weight
and Fatigue
12. Fat Metabolism
• Fat is the major form of stored energy as triglyceride
in adipose tissue or muscle fat deposits.
• TG is converted to free fatty acids plus glycerol by
lipolysis: transported to muscle for oxidation: ketone
bodies acetoacetate and –hydroxybutyrate .
• Chronic nutritional excess: accumulation of stored
fat, because ingested fat is not used and other excess
nutrients (glucose) are used to synthesize fat: fatty
liver.
13. CLINICAL IMPLICATIONS
• Elevated circulating free fatty acids from
ingested fat or lipolysis may:
• induce hepatic insulin resistance at
different sites: LIPOTOXICITY
• Increase basal HGP
• Slow the postabsorptive decline in blood
glucose.
15. Insulin and Glucose Metabolism
• Stimulates glucose uptake into muscle and
adipose cells: lipogenesis
• Inhibits hepatic glucose production
Major Metabolic Effects of
Insulin
• Hyperglycemia osmotic diuresis and
dehydration
Consequences of Insulin
Deficiency
16. Major Metabolic Effects of Insulin and Consequences of
Insulin Deficiency
Insulin effects: Stimulates glucose uptake into muscle and
adipose cells: lipogenesis + inhibits lipolysis
Consequences of insulin deficiency: elevated FFA levels
Insulin effects: Inhibits ketogenesis
• Consequences of insulin deficiency: ketoacidosis,
production of ketone bodies
Stimulates glucose uptake into muscle
stimulates amino acid uptake and protein synthesis, inhibits
protein degradation, regulates gene transcription
• Consequences of insulin deficiency: muscle wasting
19. Basal Insulin
• Constant low insulin levels
• Prevent lipolysis and glucose production.
• Low level of basal Insulin during exercise
making stored energy available.
• Low basal insulin during fasting: increase
glucagon : glycogenolysis , lipolysis, and
ketogenesis: hyperglycemia, hyperlipidemia,
and ketosis.
20. Prandial insulin
• Blood glucose is the dominant stimulus for
insulin secretion.
• Postprandial secretion increases rapidly> basal
– Suppress glucose production
– Supress lipolysis
– stimulate uptake of ingested glucose by tissues
21. The Biphasic prandial Insulin Response
Adapted from Howell SL. Chapter 9. In: Pickup JC, Williams G (Eds). Textbook of Diabetes. Oxford.
Blackwell Scientific Publications 1991: 72–83.
23. Adapted from Ward WK et al. Diabetes Care 1984; 7: 491–502.
Normal Type 2 diabetes
120
100
80
60
40
20
0
–30 0 30 60 90 120
Time (minutes)
–30 0 30 60 90 120
Time (minutes)
Plasmainsulin(µU/ml)
120
100
80
60
40
20
0
20g glucose
20g
glucose
Plasmainsulin(µU/ml)
Pattern of insulin release is altered early in Type 2 diabetes
Loss of Early-phase Insulin Release in Type 2 Diabetes
26. Glucotoxicity
• Hyperglycemia inhibits insulin secretion and
impairs insulin action.
• Oral agents that increase insulin secretion or
improve action could be ineffective at higher
levels of hyperglycemia.
• Treatment with insulin for a few days to
reduce the marked hyperglycemia may make
the patient more responsive to subsequent
treatment with oral agents.
27. FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
FPG 90 mg/dL
Normal glucose homeostasis
28. Pathophysiology in Type 2 DM
1.Decreased insulin and increased glucagon
secretion result in...
2.elevated hepatic glucose output...
3. reduced insulin-mediated glucose uptake
4.Hyperglycaemia
5.Renal glucose filtration and reabsorption is
increased up to the renal threshold for glucose
reabsorption (180 mg/dL): glucosuria
6.Glucotoxicity of all organs, exposing the
individual to the risk of complications and further
impairing insulin secretion and action
29. Pathophysiology of Type 2
diabetes
FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
1
FPG 90 mg/dL
30. Insulin resistance is the decreased
response of the liver and peripheral
tissues (muscle, fat) to insulin
Insulin resistance is a primary defect in the
majority of patients with Type 2 diabetes
Pathophysiology of Type 2 diabetes
31. Pathophysiology of Type 2
diabetes
FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
1
2
FPG 90 mg/dL
32. Pathophysiology of Type 2
diabetes
FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
1
2
3
FPG 90 mg/dL
33. Pathophysiology of Type 2
diabetes
FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
1
2
3
FPG 90 mg/dL
4
34. FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
1
2
3
4
GLUCOSURIA
GLUCOTOXICITY
FPG 180 mg/dL
Pathophysiology of Type 2 diabetes
35. FPG, fasting plasma glucose.
Adapted from: DeFronzo RA. Ann Intern Med 1999;131:281–303; Wright EM. Am J Physiol Renal Physiol 2001;280:F10–F18.
Insulin
Glucose
Glucagon
Insulin-mediated glucose uptake by
skeletal muscle and adipose tissue
Glucose
filtration/
reabsorption
1
2
3
4
GLUCOSURIA
GLUCOTOXICITY
FPG 180 mg/dL
Pathophysiology of Type 2 diabetes
38. KIDNEY
An adaptive response to
conserve glucose....
...becomes maladaptive
in Type 2 diabetes
Glucose
Normal urine GLUCOSURIA
GLUCOSE
SGLT2 plays a crucial role in
renal glucose reabsorption
This highlights renal glucose
reabsorption as a potential target
for treatment of Type 2 diabetes
In Type 2 diabetes, the
kidney’s maximum glucose
reabsorption threshold is
exceeded, resulting in
glycosuria
SGLT2, sodium-glucose co-transporter-2.
41. Mechanism of action- acarbose
Acarbose
Oligosaccharide
Acarbose
Small intestine
mucosa
Reversible inhibition of oligosaccharide
breakdown by -glucosidases
43. SGLTs
SGLT1 SGLT2
Site
Mostly intestine with some
in the kidney
Nearly exclusively in the
kidney
Sugar specificity Glucose or galactose Glucose
Affinity for glucose
High
Km = 0.4 mM
Low
Km = 2 mM
Capacity for glucose
transport
Low High
Role
Dietary glucose absorption
Renal glucose reabsorption
Renal glucose reabsorption
SGLT1/2, sodium-glucose co-transporter-1/2.
Abdul-Ghani MA, et al. Endocr Pract 2008;14:782–90.
45. Glucagon.
• The first line of defense against
hypoglycemia in normals
• Glucagon rises rapidly when blood
glucose levels fall and stimulates HGP.
• In type 1 diabetes, glucagon secretion in
response to hypoglycemia may be lost.
46. Catecholamines.
• Produced at times of stress (“fight or flight”)
• Stimulate release of stored energy.
• Major defense against hypoglycemia in T1M
(POOR glucagon).
• IF DEFECTIVE: Hypoglycemia unawareness:
severe and prolonged hypoglycemia:
• Intensified glucose control only after a period
of hypoglycemia avoidance and restoration of
catecholamine response.
47. Cortisol.
• increases at times of stress.
• stimulate gluconeogenesis.
• slower than glucagon
• not effective in protecting against
acute hypoglycemia.
48. Growth hormone
• Slow effects on glucose metabolism.
• major surge during sleep : rise in blood
glucose levels in the early morning: dawn
phenomenon.
• In normal physiology, a slight increase in
insulin secretion compensates
• In diabetes: variable morning hyperglycemia
related to variable nocturnal growth hormone
secretion.
49.
50. T1D and advanced T2D: counterregulatory
deficiencies and impaired symptomatic awareness
52. Hypoglycemia Unawareness
• No early warning symptoms of hypoglycemia
• cognitive impairment may be first symptom
• Clinical diagnosis
• Reduced glucose thresholds for epinephrine-mediated warning
symptoms
• Autonomic dysfunction: inadequate catecholamic release to
hypoglycemia.
53. Reversible!!
• Avoidance of even mild hypoglycemia for 2–4 weeks.
• Adjustments in glycemic goals
• Education to estimate and detect blood glucose level
fluctuations.
• Increased monitoring of blood glucose
• Modifying glycemic targets until hypoglycemia awareness is
regained.
• Symptom recognition
• AFTER regaining hypoglycemia awareness: reassess the
treatment plan to avoid episodes of hypoglycemia, especially
• nocturnal hypoglycemia.